CoV-2 Spike (300-600)

Coronavirus 2019 Spike Receptor Binding Domain (300-600 a.a.) Recombinant
Shipped with Ice Packs
In Stock

Description

Receptor Binding

  • The RBD (residues 319–541) binds ACE2 via residues ASN487, TYR449, and LYS417 .

  • D614G mutation (residue 614) enhances spike stability and ACE2 affinity by 4–5× .

Conformational Dynamics

  • Prefusion State: RBD alternates between "up" (open) and "down" (closed) conformations .

  • Open Trimer: Exposure of residues 300–600 increases accessibility for ACE2 and antibodies .

Mutation Landscape and Variants

Key mutations in residues 300–600 across variants:

VariantMutationsImpact on Spike FunctionSource
Alpha (B.1.1.7)N501Y↑ ACE2 affinity
Gamma (P.1)K417T, E484KImmune evasion
Omicron BA.1G339D, S371L, S373PAltered RBD dynamics

Antibody Interactions

  • RAY53 Antibody: Targets conserved hinge region (residues 980–1006 in S2), adjacent to 300–600 .

  • Neutralizing Antibodies: Bind RBD epitopes (e.g., residues 453–506) to block ACE2 attachment .

Vaccine Design

  • Stabilized spikes (e.g., HexaPro) with residues 300–600 modifications show 16× higher neutralizing titers vs. wild-type .

  • Failure Modes: Mutations like E484K reduce antibody efficacy by 10–20× .

Biochemical Assays

  • Binding Affinity: ACE2-Spike (300–600) KD = 15 nM .

  • MD Simulations: ΔG TOTAL for C3 (−38.0 ± 0.08 kcal/mol) and C6E (−41.98 ± 0.08 kcal/mol) inhibitors .

Cryo-EM Data

  • Closed State (6VXX): RBD predominantly "down" .

  • Open State: RBD "up" conformation exposes residues 440–460 for ACE2 docking .

Evolutionary Conservation

  • Residues 483–507 in RBD are 92% conserved across sarbecoviruses .

  • D614G prevalence: >99% in global sequences post-2020 due to fitness advantage .

Product Specs

Introduction

In December 2019, a novel coronavirus, designated 2019-nCoV, emerged in Wuhan, China, causing an outbreak of viral pneumonia. This virus was linked to a seafood market in the city.

Genetic analysis revealed that 2019-nCoV shares a high degree of similarity (87%) with a bat-derived SARS-like coronavirus (SARS-CoV-2) previously identified in Zhoushan, eastern China. Notably, 2019-nCoV possesses a similar receptor-binding domain (RBD) structure to SARS-CoV, suggesting a potential to bind to the human ACE2 receptor, despite some amino acid variations.

While bats are considered the likely natural reservoir of 2019-nCoV, an intermediate animal host, possibly present at the seafood market, is suspected to have played a role in its transmission to humans. Research indicates that 2019-nCoV may have arisen from recombination events involving a bat coronavirus and an unidentified coronavirus, particularly in the spike glycoprotein region.

Description

This product consists of the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein (amino acids 300-600), produced in E. coli. This immunodominant region is fused to a C-terminal 6xHis tag for purification and detection purposes.

Physical Appearance
A transparent liquid that has been sterilized by filtration.
Formulation

The CoV 2019 Spike Receptor Binding Domain Protein is provided at a concentration of 1 mg/ml in a solution of 1x PBS (phosphate-buffered saline).

Stability

The CoV 2019 Spike Receptor Binding Domain Protein is shipped with ice packs to maintain its integrity. Upon receipt, it should be stored at a temperature of -20 degrees Celsius.

Purity

The purity of the CoV 2019 Spike Receptor Binding Domain Protein is greater than 90%, as determined by SDS-PAGE analysis.

Source
Escherichia Coli.

Q&A

What is the significance of the 300-600 amino acid region in the SARS-CoV-2 spike protein?

The 300-600 amino acid region of the SARS-CoV-2 spike protein encompasses critical functional domains including portions of the receptor-binding domain (RBD) and elements involved in the conformational changes required for viral fusion. This region plays a vital role in ACE2 receptor binding and contains numerous epitopes targeted by neutralizing antibodies. The region's importance is highlighted by its metastability, which allows the protein to undergo the dramatic shape changes necessary for membrane fusion during viral entry. The spike protein is the main immunogenic component used in vaccine development and a primary target for therapeutic interventions .

How does the SARS-CoV-2 spike protein change conformation during viral entry?

The SARS-CoV-2 spike protein undergoes dramatic conformational changes during viral entry. Initially, in its prefusion state, the spike protein binds to the ACE2 receptor on human cells. This binding triggers a substantial structural rearrangement where the protein "jack-knives," folding in on itself to form a rigid hairpin shape (post-fusion state). This conformational change facilitates fusion between the viral membrane and the host cell membrane, enabling viral entry. Cryogenic electron microscopy has successfully freeze-framed these distinct "before" and "after" shapes, revealing the molecular basis of this process .

Interestingly, research has shown that the spike protein can prematurely transition from its prefusion to post-fusion conformation even without cell binding, suggesting multiple pathways for these conformational changes. This finding has significant implications for understanding viral stability and designing interventions that could lock the protein in a specific conformation .

What structural features make the SARS-CoV-2 spike protein challenging to work with experimentally?

The SARS-CoV-2 spike protein presents several experimental challenges due to its unique structural features:

  • Metastability: The protein exists in a metastable prefusion state that can spontaneously transition to the post-fusion state, complicating consistent preparation .

  • Size and complexity: As a large trimeric class I fusion membrane protein, it is structurally complex and difficult to express recombinantly in high yields .

  • Extensive glycosylation: The protein is heavily glycosylated, which affects protein folding, stability, and antigenic properties .

  • Membrane association: The native protein is membrane-bound, requiring careful design of soluble constructs that maintain native-like properties .

  • Conformational heterogeneity: The spike exists in multiple conformations with different receptor-binding domain orientations (up and down states), complicating structural studies and antibody development .

These characteristics have necessitated specialized approaches such as introducing stabilizing proline mutations (as in the HexaPro construct) that maintain the prefusion conformation and improve expression yields .

What protocols are recommended for expressing and purifying recombinant SARS-CoV-2 spike protein for research applications?

For efficient expression and purification of SARS-CoV-2 spike protein, researchers have developed optimized protocols that maximize yield and stability. The HexaPro construct with six stabilizing proline substitutions has demonstrated superior results with expression yields exceeding 30 mg/L in ExpiCHO cells .

Recommended expression protocol:

  • Cell culture systems: Use either Freestyle 293 or ExpiCHO cell lines, with ExpiCHO providing higher yields .

  • Construct design: Utilize prefusion-stabilized spike variants like HexaPro that contain stabilizing mutations to maintain the protein in its prefusion conformation .

  • Transfection to purification timeline: The complete protocol from transfection to biophysical characterization typically takes approximately 7 days .

  • Quality control: Implement rigorous quality control steps including SDS-PAGE, size-exclusion chromatography, and functional binding assays to ensure proper folding and activity .

  • Storage conditions: Proper storage conditions, typically involving flash-freezing aliquots and storing at -80°C, preserve the protein's structural integrity and functional properties for downstream applications .

This protocol has been validated for purifying over 100 different spike variants, making it widely applicable for research on various spike protein constructs and mutants .

What techniques are most effective for studying the conformational changes of the spike protein?

Studying the dynamic conformational changes of the SARS-CoV-2 spike protein requires specialized techniques that can capture different structural states:

  • Cryogenic electron microscopy (cryo-EM) has proven most effective for visualizing distinct conformational states of the spike protein. This technique successfully freeze-frames the protein in both its prefusion and post-fusion states, providing high-resolution structural information without requiring protein crystallization .

  • Hydrogen-deuterium exchange mass spectrometry (HDX-MS) can map conformational dynamics and flexibility in different regions of the spike protein, providing insights into which domains undergo significant structural rearrangements during the transition between conformational states .

  • Single-molecule Förster resonance energy transfer (smFRET) can track real-time conformational changes in individual spike protein molecules, particularly useful for monitoring the dynamics of receptor binding domain movements between "up" and "down" conformations .

  • Molecular dynamics simulations complement experimental data by modeling the energetics and kinetics of spike protein conformational changes at atomic resolution, helping to identify transition states and energy barriers between different conformations .

  • Differential scanning calorimetry and circular dichroism spectroscopy provide thermodynamic stability profiles that can be used to assess the effects of mutations or ligand binding on conformational stability .

These complementary approaches provide multi-scale insights into spike protein dynamics essential for understanding its function and developing interventions that target specific conformational states .

How has the D614G mutation impacted the structure and function of the spike protein?

The D614G mutation in the SARS-CoV-2 spike protein represents one of the earliest and most significant adaptations of the virus, reaching near fixation globally within months of its emergence. This mutation, located in the S1 subunit of the spike protein, has profound structural and functional consequences:

  • Increased stability: The D614G mutation enhances the stability of the prefusion conformation of the spike protein, resulting in fewer S1 subunit shedding events and more intact spike proteins on the viral surface .

  • Prevalence and selection: First reported in January 2020 in virus genomes from China and Germany, D614G rapidly increased in frequency, becoming present in approximately 74% of all sequenced SARS-CoV-2 genomes by mid-2020, indicating strong positive selection .

  • Transmission advantage: The mutation provides increased viral infectivity and transmissibility, likely contributing to the rapid global spread of variants containing this mutation .

  • Impact on antibody recognition: Despite its location outside the receptor-binding domain, D614G can potentially affect the presentation of neutralizing epitopes by altering the conformational dynamics of the spike protein .

  • Molecular mechanism: The mutation affects the interface between neighboring protomers in the spike trimer, altering the probability of the receptor-binding domain adopting the "up" conformation required for ACE2 binding .

This mutation demonstrates how seemingly subtle single amino acid changes can dramatically impact viral fitness and highlights the importance of ongoing surveillance of emerging spike variants .

What is the significance of mutations at the P681 position in different SARS-CoV-2 variants?

Mutations at position P681 of the spike protein, found adjacent to the furin cleavage site, have emerged independently in multiple variants of concern (VOCs) and have significant implications for viral function:

  • Location and function: P681 is part of the unique furin cleavage motif (680SPRRAR↓SVAS689) found in SARS-CoV-2 but absent in closely related coronaviruses. This site is critical for the cleavage of spike into S1 and S2 subunits, a prerequisite for subsequent TMPRSS2-mediated cleavage at the S2' site that triggers cell fusion and viral entry .

  • Variant-specific mutations: Multiple VOCs have independently developed mutations at this position:

    • Alpha and Omicron variants: P681H mutation

    • Delta variant: P681R mutation

  • Structural implications: P681 is located in a flexible loop region of the spike protein, making proline substitutions structurally viable despite proline's unique conformational constraints .

  • Impact on furin cleavage: Both P681H and P681R mutations enhance furin-mediated cleavage efficiency, potentially increasing viral fusion capacity and infectivity .

  • Immunological significance: The region containing P681 forms part of a highly immunogenic epitope recognized by antibodies from COVID-19 patients, suggesting mutations here may affect immune recognition .

  • Blocking effect: Research indicates that the P680H mutation (found in Alpha and Omicron variants) may block certain interactions of the spike protein, potentially affecting inflammatory pathways triggered during infection .

The convergent evolution of mutations at this position in multiple VOCs suggests a significant selective advantage, highlighting the crucial role of the furin cleavage site in SARS-CoV-2 pathogenesis and adaptation .

How do stabilizing proline mutations improve spike protein expression and stability for research and vaccine applications?

The introduction of stabilizing proline mutations in the SARS-CoV-2 spike protein represents a sophisticated protein engineering approach with significant benefits for research and vaccine development:

This structure-based engineering approach demonstrates how rational protein design can overcome natural limitations of metastable viral fusion proteins, with broad implications for both basic research and vaccine development .

What methodologies are most effective for analyzing spike protein interactions with potential therapeutic agents?

Analyzing interactions between the SARS-CoV-2 spike protein and potential therapeutic agents requires sophisticated methodological approaches that provide both structural and functional insights:

  • Surface plasmon resonance (SPR) and bio-layer interferometry (BLI): These label-free biophysical techniques provide real-time kinetic data on binding interactions, determining association and dissociation rates and equilibrium binding constants for antibodies, receptor decoys, or small molecule inhibitors .

  • Cryo-electron microscopy (Cryo-EM): High-resolution structural analysis of spike protein complexed with therapeutic antibodies or inhibitors can reveal precise binding epitopes and conformational effects, guiding structure-based drug design and antibody engineering .

  • X-ray crystallography: When applicable, crystallographic studies of the receptor-binding domain or other spike subdomains in complex with therapeutic agents provide atomic-resolution details of binding interfaces .

  • Pseudovirus neutralization assays: These functional assays measure the ability of therapeutic agents to block viral entry, providing critical validation of binding studies in a more physiologically relevant context that mimics the natural infection process .

  • Hydrogen-deuterium exchange mass spectrometry (HDX-MS): This technique can map conformational changes induced by therapeutic binding, identifying allosteric effects and distinguishing between different mechanistic classes of inhibitors .

  • Computational docking and molecular dynamics simulations: These approaches can screen large libraries of potential therapeutic compounds in silico and predict binding modes and induced conformational changes, prioritizing candidates for experimental validation .

  • Cell-cell fusion assays: These functional assays assess the ability of spike-expressing cells to fuse with ACE2-expressing target cells in the presence of potential fusion inhibitors, providing insights into post-binding steps of viral entry .

The combination of these complementary methodologies provides a comprehensive understanding of therapeutic agent interactions with the spike protein, enabling rational optimization of binding affinity, specificity, and functional inhibition .

How do spike protein conformational states influence vaccine design and efficacy?

The conformational states of the SARS-CoV-2 spike protein significantly impact vaccine design and efficacy through multiple mechanisms:

  • Prefusion vs. post-fusion targeting: Antibodies elicited against the prefusion conformation are generally more neutralizing than those targeting the post-fusion state. Consequently, vaccines designed to present stable prefusion spike conformations (like those incorporating proline stabilizing mutations) typically induce more potent neutralizing antibody responses .

  • Epitope accessibility and immunodominance: Different conformational states expose distinct epitopes, influencing which antibodies are predominantly generated following vaccination. The dynamic nature of the receptor-binding domain (RBD), which can adopt "up" and "down" conformations, affects the accessibility of key neutralizing epitopes .

  • Stability considerations: The metastability of the native spike protein poses challenges for vaccine formulation and storage. Engineered stabilized versions like HexaPro maintain the prefusion conformation during production, purification, and delivery, preserving critical neutralizing epitopes that might otherwise be lost during spontaneous conformational changes .

  • Cross-variant protection: Understanding how mutations in variant strains affect spike protein conformation helps predict cross-protection of vaccines against emerging variants. Some mutations alter the conformational dynamics of the spike, potentially exposing or concealing different epitopes and affecting antibody recognition .

  • Next-generation design approaches: Knowledge of both prefusion and post-fusion states guides the design of structure-based vaccines that can present specific stabilized conformations or conserved epitopes that remain accessible across conformational states, potentially broadening protection against diverse coronaviruses .

The ability to express, characterize, and stabilize specific spike protein conformations has been instrumental in the rapid development of highly effective COVID-19 vaccines and continues to inform strategies for improving vaccine breadth and durability .

What are the methodological considerations for developing diagnostics based on the spike protein?

Developing effective diagnostic tools based on the SARS-CoV-2 spike protein requires careful methodological considerations across multiple technical dimensions:

  • Protein expression and stability: For antigen-based tests, using stabilized spike protein constructs like HexaPro ensures consistent quality and higher yields. Prefusion-stabilized variants prevent conformational shifting that could otherwise alter epitope presentation and affect diagnostic accuracy .

  • Sampling considerations: Research has shown promising results using saliva samples for spike gene amplification, offering a non-invasive alternative for large-scale screening. This approach is facilitated by expression of ACE2 receptors in salivary glands, gingiva, oral mucosa, and tongue tissues that can harbor SARS-CoV-2 .

  • Detection platform selection:

    • RT-PCR assays: Targeting conserved regions of the spike gene provides reliable detection but requires careful primer design to avoid missing virus variants with mutations in the target region .

    • ELISA-based methods: Using spike protein or receptor-binding domain as capture antigens for detecting patient antibodies, with considerations for coating density, buffer optimization, and cross-reactivity controls .

    • Point-of-care lateral flow immunoassays: Require optimization of spike protein fragments to maximize sensitivity and specificity while maintaining stability under ambient conditions .

    • Graphene-based field-effect transistor (FET) biosensors: Can provide rapid, highly sensitive detection of spike protein with considerations for surface functionalization and signal amplification strategies .

  • Variant detection: Diagnostic designs must account for emerging spike variants, potentially targeting multiple regions or incorporating multiplex approaches to distinguish different variants or detect shared conserved epitopes .

  • Standard reference materials: Development of well-characterized spike protein reagents with defined conformational states is essential for assay standardization and inter-laboratory validation .

  • Validation with diverse sample cohorts: Testing across different patient populations, disease severities, and time points post-infection is critical for establishing diagnostic sensitivity, specificity, and temporal detection windows .

These methodological considerations highlight the importance of understanding spike protein structure, conformational dynamics, and variant evolution for developing robust diagnostic tools that maintain accuracy across the evolving pandemic landscape .

Product Science Overview

Introduction

The Coronavirus 2019 (SARS-CoV-2) is the causative agent of the COVID-19 pandemic. A critical component of this virus is its spike (S) protein, which facilitates viral entry into host cells. The spike protein contains a receptor-binding domain (RBD) that specifically interacts with the angiotensin-converting enzyme 2 (ACE2) receptor on human cells. The RBD is a key target for therapeutic interventions and vaccine development due to its crucial role in viral infectivity.

Structure and Function

The spike protein of SARS-CoV-2 is a trimeric class I fusion protein composed of two subunits, S1 and S2. The S1 subunit contains the RBD, which spans approximately 300-600 amino acids (a.a.). This domain is responsible for binding to the ACE2 receptor, initiating the process of viral entry into the host cell .

The RBD undergoes conformational changes to facilitate binding to ACE2. In its “up” conformation, the RBD is accessible for receptor binding, while in the “down” conformation, it is less accessible. This dynamic nature of the RBD is crucial for the virus’s ability to evade the host immune system and enhance infectivity .

Recombinant RBD

Recombinant RBD proteins are produced using various expression systems, such as mammalian cells, insect cells, and yeast. These recombinant proteins are used in research to study the interaction between the spike protein and ACE2, as well as in the development of vaccines and therapeutic antibodies .

The recombinant RBD spanning 300-600 a.a. is particularly significant because it includes the critical residues involved in ACE2 binding. This region has been extensively studied to understand the molecular determinants of virus-host interactions and to identify potential targets for neutralizing antibodies .

Applications in Research and Medicine
  1. Vaccine Development: The RBD is a prime target for vaccine development. Vaccines that elicit an immune response against the RBD can potentially block the virus from binding to ACE2, thereby preventing infection. Several COVID-19 vaccines, including mRNA vaccines, have been designed to induce antibodies against the RBD .

  2. Therapeutic Antibodies: Monoclonal antibodies targeting the RBD have shown promise in neutralizing the virus. These antibodies can bind to the RBD, preventing it from interacting with ACE2 and thereby inhibiting viral entry into host cells .

  3. Diagnostic Tools: Recombinant RBD proteins are used in serological assays to detect antibodies against SARS-CoV-2 in patient samples. These assays help in understanding the immune response to infection and vaccination .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.